Particle.news

Download on the App Store

Bayer Extends Anderson’s Contract to 2029 as CEO’s Turnaround Gains Traction

Board endorsement of Anderson’s leadership signals confidence in his multi-pronged glyphosate liability strategy as well as his €2 billion cost savings drive.

Overview

  • Anderson’s mandate now runs through March 2029 after unanimous approval by Bayer’s supervisory board.
  • He has advanced a multi-pronged approach to contain over 60,000 legacy glyphosate lawsuits inherited from the Monsanto takeover.
  • Since 2023, Bayer has cut 11,000 positions, flattened hierarchies and pushed for greater employee autonomy to streamline operations.
  • The company remains on track to achieve €2 billion in cost savings for 2026 thanks to job reductions and reorganized workflows.
  • Despite persistent weakness in its agribusiness, Bayer’s share price has recovered by about €8 since April, trading above €27 per share.